Delivery Order SPE2DB20D3104-SPE2DB25FV5M4

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract is a Firm Fixed Price arrangement with a ceiling value of $4,734.26 and an ultimate completion date of August 20, 2024. The contract is not set aside for any specific business category. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Vivitrol 380 mg vials and diluents. The contract has a ceiling value of $11,180.53 and a completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a firm fixed price and a ceiling value of $11,886.03, with a completion date of November 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $2,678.46 and runs through May 31, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialty medication, with a ceiling value of $1,192.03 and a completion date of October 26, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,589.11 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565057997 Vivitrol 380 mg vials and diluents. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The delivery order is valued at $2,642.05 and has a completion date of June 12, 2024. It is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order, valued at $10,971.72, is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialty pharmaceutical product. The delivery order was issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 380 mg vials of Vivitrol, a medication used to treat opioid dependence. The contract is a firm-fixed price delivery order with a ceiling value of $16,058.67 and a performance period ending on September 5, 2024. AmerisourceBergen has been awarded multiple indefinite-delivery contracts (IDCs) with the DLA and other federal agencies to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vivitrol 380 mg vials and diluents, a medication used for the treatment of alcohol and opioid dependence. The contract has a ceiling value of $4,571.55 and a performance period through February 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV5M4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,385.97, is for the supply of Vivitrol 380 mg vials and diluents. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/28/25, 11:03 AM